Alpine Immune Sciences Inc (NAS:ALPN)
$ 64.94 0.12 (0.19%) Market Cap: 4.45 Bil Enterprise Value: 3.93 Bil PE Ratio: 0 PB Ratio: 11.96 GF Score: 61/100

Q3 2022 Alpine Immune Sciences Inc Earnings Call Transcript

Nov 14, 2022 / 09:30PM GMT
Release Date Price: $5.74 (-0.52%)
Operator

Please stand by. Welcome to the Alpine Immune Sciences third-quarter earnings call. Currently, all participants are in a listen-only mode. As a reminder, this event is being recorded.

I would now like to introduce Temre Johnson, Senior Director of Investor Relations and Corporate Communications at Alpine. Ms. Johnson, I will now turn the call over to you.

Temre Johnson
Alpine Immune Sciences, Inc. - Senior Director of IR & Corporate Communications

Thank you, operator. Good afternoon, and thank you for joining us. With me on today's call are Dr. Mitchell Gold, Executive Chairman and Chief Executive Officer; Dr. Stanford Peng, President and Head of R&D; Dr. Andrew Sandler, Chief Medical Officer; Paul Rickey, Chief Financial Officer; and Dr. Remy Durand, Chief Business Officer.

Before I turn the call over to Mitch, I would like to remind you that we'll be making forward-looking statements during the course of today's call. I encourage you to refer to the most recent SEC filings regarding the risk factors associated with these statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot